Jasmine Martin, Director, West Region Medical Science Liaison Team, Takeda Oncology, discusses oral adherence.
Jasmine Martin
Advertisement
Articles by Jasmine Martin
Advertisement
Latest Updated Articles
Jasmine Martin Discusses Oral AdherenceMay 1st 2015
Advertisement
Advertisement
Trending on CURE
1
Medicare Part D 2027: What a $2,400 Cap Means for Cancer Drugs
2
FDA Approves Imfinzi Plus Padcev for Some With Muscle-Invasive Bladder Cancer
3
5 Lung Cancer Survival Numbers Patients Should Know in 2026
4
Tattoos and Lymphoma Risk: A Breast Cancer Survivor's Questions
5